- Home
- / Achilles Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Achilles Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$138.1 M
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|
| General and administrative expense | 4.7M | 11.1M | 22.0M | 21.1M | 17.0M |
| Operating expense total | 13.8M | 33.7M | 78.4M | ||
| EBIT | (13.8M) | (33.7M) | (64.2M) | (78.4M) | (75.3M) |
| Pre tax profit | (14.0M) | (33.2M) | (61.1M) | (71.1M) | (69.2M) |
| Income tax expense | (3.0K) | 37.0K | 111.0K | 491.0K | |
| Net Income | (14.0M) | (33.2M) | (61.1M) | (71.2M) | (69.7M) |
| EPS | (5.5) | (7.9) | (1.8) | (1.0) |